Skip to content
Blog

The First Step to E-prescribing Controlled Substances Has Been Taken!

DrFirst has released a press release in response to the June 3rd healthcare IT milestone.  Dr. Tom Sullivan performed the first ever live demonstration of sending a controlled substance electronically at the 2010 AHRQ Annual Health IT Grantee and Contractor meeting in Washington, DC.   This fully operational system was developed under an AHRQ funded grant in collaboration with the Massachusetts Department of Public Health, Berkshire Health Systems, Inc., eRx Network, and Brandeis University’s Heller School for Social Policy and Management and contains the necessary security features required to operate under a special waiver from the DEA.


“Our focus now is to bring these capabilities to the more than 100 EMR, practice management, and hospital information system vendors who partner with DrFirst for e-prescribing.”  – G. Cameron Deemer, President of DrFirst


Read the entire press release at:
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100603006917&newsLang=en
We will be posting a video of the demonstration at http://www.youtube.com/drfirst in the coming days so stay tuned!

avatar

DrFirst

Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare efficiency and effectiveness by enhancing e-prescribing workflows, improving medication history, optimizing clinical data usability, and helping patients start and stay on therapy. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions are used by more than 350,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. and Canada. To learn more, visit DrFirst.com and follow @DrFirst.

What To Read Next